Literature DB >> 22872284

Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?

Aibek E Mirrakhimov1.   

Abstract

INTRODUCTION: Obstructive sleep apnea (OSA) is a common medical disorder affecting at least 2 % of women and 4 % of men living in Western societies. Obesity, older age, male gender, alcohol and sedative use, smoking, craniofacial parameters, and volume overload are some of the risk factors for this disorder. DISCUSSION: OSA is a known risk factor complicating the course of arterial hypertension, heart failure, and chronic kidney disease. It is important to note that all of the aforementioned comorbid disorders are associated with volume overload. This explains why patients with OSA and comorbid disorders associated with fluid overload can benefit from treatment with diuretics and drugs modulating the renin-angiotensin-aldosterone system. Additionally, patients with heart failure and high sodium intake are at increased risk for OSA, further supporting the complex interrelationship.
CONCLUSIONS: Hemodialysis and renal transplantation can markedly improve the severity of OSA in patients with concomitant kidney disease. Finally, there is a potential of a vicious cycle between OSA and fluid overload disorders, whereby OSA can contribute to the pathogenesis of arterial hypertension, heart failure, and chronic kidney disease, which in turn will significantly contribute to the course OSA.

Entities:  

Mesh:

Year:  2012        PMID: 22872284     DOI: 10.1007/s11325-012-0755-6

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  107 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Renin-angiotensin-aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism.

Authors:  A Di Murro; L Petramala; D Cotesta; L Zinnamosca; E Crescenzi; C Marinelli; M Saponara; C Letizia
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2010-05-20       Impact factor: 1.636

3.  High prevalence of unrecognized sleep apnoea in drug-resistant hypertension.

Authors:  A G Logan; S M Perlikowski; A Mente; A Tisler; R Tkacova; M Niroumand; R S Leung; T D Bradley
Journal:  J Hypertens       Date:  2001-12       Impact factor: 4.844

4.  Sleep apnea, coronary artery disease, and antioxidant status in hemodialysis patients.

Authors:  Hae Hyuk Jung; Heon Han; Jung Hie Lee
Journal:  Am J Kidney Dis       Date:  2005-05       Impact factor: 8.860

5.  Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension.

Authors:  Rodrigo P Pedrosa; Luciano F Drager; Carolina C Gonzaga; Marcio G Sousa; Lílian K G de Paula; Aline C S Amaro; Celso Amodeo; Luiz A Bortolotto; Eduardo M Krieger; T Douglas Bradley; Geraldo Lorenzi-Filho
Journal:  Hypertension       Date:  2011-10-03       Impact factor: 10.190

6.  Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension.

Authors:  Monique N Pratt-Ubunama; Mari K Nishizaka; Robyn L Boedefeld; Stacey S Cofield; Susan M Harding; David A Calhoun
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

7.  High prevalence of patients with a high risk for obstructive sleep apnoea syndrome after kidney transplantation--association with declining renal function.

Authors:  Miklos Zsolt Molnar; Andras Szentkiralyi; Anett Lindner; Maria Eszter Czira; Andras Szabo; Istvan Mucsi; Marta Novak
Journal:  Nephrol Dial Transplant       Date:  2007-05-03       Impact factor: 5.992

8.  Nocturnal haemodialysis increases pharyngeal size in patients with sleep apnoea and end-stage renal disease.

Authors:  Jaime M Beecroft; Victor Hoffstein; Andreas Pierratos; Christopher T Chan; Philip McFarlane; Patrick J Hanly
Journal:  Nephrol Dial Transplant       Date:  2007-09-22       Impact factor: 5.992

9.  Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance.

Authors:  Sydney C W Tang; Bing Lam; Andrew S H Lai; Clara B Y Pang; Wai Kuen Tso; Pek Lan Khong; Mary S M Ip; Kar Neng Lai
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 8.237

10.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

View more
  3 in total

Review 1.  Obstructive sleep apnoea and risks of all-cause mortality: preliminary evidence from prospective cohort studies.

Authors:  Lei Pan; Xiaomei Xie; Dayue Liu; Dunqiang Ren; Yongzhong Guo
Journal:  Sleep Breath       Date:  2016-01-15       Impact factor: 2.816

Review 2.  Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony.

Authors:  Aibek E Mirrakhimov
Journal:  Cardiovasc Diabetol       Date:  2012-10-27       Impact factor: 9.951

Review 3.  Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea?

Authors:  Aibek E Mirrakhimov
Journal:  Cardiovasc Diabetol       Date:  2014-01-30       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.